Oncology & Cancer

Helping patients navigate new cancer drugs

As cancer treatment in pill form transforms how care is delivered, a new Michigan State University study underscores the challenges patients face in administering their own chemotherapy outside the supervised environment ...

Medications

Signifor approved for Cushing's disease

(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.

Medications

Cometriq approved for rare thyroid cancer

(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.

Diseases, Conditions, Syndromes

Probiotics show potential to minimize C. difficile

(Medical Xpress)—New cases of C. difficile-associated diarrhea among hospitalized patients taking antibiotics can be reduced by two-thirds with the use of probiotics, according to new research published Monday in the Annals ...

Health

Tips on exercising, or not, when you are sick

Stuffy noses, hacking coughs and aches all over—cold and flu season has arrived. Though your body may be aching and your nose running like a faucet, it can be difficult to decide if you should continue your exercise routine ...

Arthritis & Rheumatism

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

page 11 from 24